Big Gain For Pyxis Oncology Inc.
Tue, Mar 28, 2023 at 07:10 PM
Pyxis Oncology Inc. (PYXS:NASDAQ) rocketted at $3.85, representing a gain of 42.6%. On Tue, Mar 28, 2023, PYXS:NASDAQ hit a New 2-Week High of $3.85. The stock got featured on our News Catalysts scanner on Wed, Mar 22, 2023 at 06:53 AM in the 'INVESTOR UPDATE' category. From Tue, Mar 14, 2023, the stock recorded 60.00% Up Days and 45.45% Green Days
About Pyxis Oncology Inc. (PYXS:NASDAQ)
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients.
Top 10 Gainers:
- Biomea Fusion Inc. (BMEA:NASDAQ), 99.03%
- Viking Therapeutics, Inc. (VKTX:NASDAQ), 69.3%
- Oscar Health Inc. Class A (OSCR:NYSE), 56.27%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 50.17%
- Pyxis Oncology Inc. (PYXS:NASDAQ), 42.59%
- Bird Global Inc. Class A (BRDS:NYSE), 42.19%
- MGO Global Inc. (MGOL:NASDAQ), 33.33%
- Knightscope Inc. (KSCP:NASDAQ), 31.19%
- Loop Industries, Inc. (LOOP:NASDAQ), 23.41%
- Tiziana Life Sciences PLC (TLSA:NASDAQ), 22.4%